Cara Therapeutics | CARA - Trade Debtors


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Cara Therapeutics

Cara Therapeutics reported $7.26M in Trade Debtors for its fiscal quarter ending in March of 2023.


Trade Debtors Change
Acadia Pharmaceuticals ACAD:US USD 70.25M 7.17M
Cara Therapeutics CARA:US USD 7.26M 2.8M
Chugai Pharma 4519:JP JPY 362.54B 151.74B
Depomed DEPO:US USD 47.44M 2.08M
Endo International ENDP:US USD 465.71M 36.89M
Halozyme Therapeutics HALO:US USD 194.88M 36.19M
Horizon Pharma HZNP:US USD 624.7M 51.65M
J&J JNJ:US USD 16.35B 190M
Neurocrine Biosciences NBIX:US USD 391.6M 41.6M
Pacira PCRX:US USD 93.2M 5.19M
RedHill Biopharma RDHL:US USD 34.52M 1.49M
Revance Therapeutics RVNC:US USD 15.37M 4.03M
Supernus Pharmaceuticals SUPN:US USD 143.57M 21.93M
Vanda Pharmaceuticals VNDA:US USD 24.51M 9M